European Commission is world's largest public investor in nanotechnology
European Commission - IP/07/1321 13/09/2007
Brussels, 13 September 2007
With €1.4 billion allocated to 550 projects in the field of nanosciences and nanotechnology, the EU's 6th Research Framework Programme accounts for one-third of total public funding for nanotechnology and is the world's largest single funding agency worldwide for this exciting field. A recent report, focused on the implementation of the 2005 Action Plan for Nanotechnology, shows the strategic importance of nanotechnology, an area of recognised European leadership, and the contribution this field of science can make to the quality of life and economic well-being of Europeans, for example through revolutionary activities in key areas such as materials, electronics and medicine. The European Commission is committed to an integrated and responsible approach to developing nanotechnologies, taking into account all aspects – safety, acceptance by society, ethical implications and so on.
"Nanotechnology is an area where Europe is an acknowledged world leader. This is an opportunity we must grasp with both hands," says European Science and Research Commissioner Janez Potočnik. "The successful development of nanotechnologies will depend on a responsible approach to addressing issues such as safety for humans and animals, the ethics of future developments and society's debate about these. The European Commission has already shown in this first phase that it is able to steer this course."
Nanotechnology is a broad term that has applications in many fields of science – biology, electronics, materials, medicine – but broadly encompasses research into the principles and properties arising at the nano-level, that is the level of atoms and molecules. These can differ significantly from the larger scale, which is why this new area of science has emerged. Nanotechnologies make possible better products and services, helping to improve citizens' quality of life and environment. Many nanotechnology-based products are already on the market, including new electronics and chemistry components, intelligent textiles, novel functional surface coatings, new diagnostic and drug delivery systems, breakthroughs in tissue regeneration, and ever faster and more accurate sensors.
The EU's 6th Research Framework Programme provided €1.4 billion to 550 projects, accounting for on-third of total public funding for nanotechnology in Europe. Priority targets include fundamental and industrial research, human resources, nanotechnology-specific infrastructures, safety and communication. Although there is strong industrial participation in these projects, resulting in innovation in companies (including SMEs), more and more patents and spin-offs, and a better environment for research and industry (standards, metrology, patenting etc), private investment in the field remains behind that in the US and Japan.
Under FP7, EC funding for nanotechnologies and nanosciences is expected to increase significantly. The average yearly funding is likely to be more than double that in FP6, taking into account actions across the programme. In addition, the Risk-Sharing Financing Facility established by the Commission jointly with the European Investment Bank should provide access to new funding sources.
Beyond funding, the successful development of nanotechnologies demands an integrated and responsible approach. European citizens should benefit from nanotechnology, while being protected from possible adverse impacts. Commitment to ethical principles is a cornerstone of such an approach. To reach full potential, nanotechnology development must be attuned to society's expectations, making communication and dialogue an absolute priority. In addition to information activities in all Community languages for different target groups, the Commission has systematically promoted public dialogue, particularly with NGOs. It has launched an open consultation on a Code of Conduct for responsible nanotechnology research, which may lead to a Commission recommendation by the end of the year.
Similarly, assessing the safety of nanotechnology-based products and processes is a central issue for European policy, and has direct impact on their access to the market. Nanoparticles and their potential impact on health and the environment are being studied in close coordination with Member States and international bodies such as the UN, OECD and International Standards Organisation. In addition to projects specifically devoted to safety, which have received €28 million in funding so far, all nanotechnology research projects include an ethical and safety assessment component. The European Commission is currently undertaking a review of existing legislation to see whether the current regulatory framework appropriately addresses health, safety and environmental risks. Moreover, it has taken steps to establish an observatory to provide decision-makers with dynamic assessments of scientific and market developments.
Other important issues discussed in the report are the international aspects of nanotechnology development, and the need to train the new generation of nano-scientists.
For more information:
Consultation on responsible governance: IP/07/1140
Risk Sharing Finance Facility: IP/07/761